advertisement
11.1 General management, indication (8)
Showing records 1 to 8
Display all abstracts in classification 11.1 General management, indication
Search within classification 11.1 General management, indication19834 Effect of anti-glaucoma topical medications on expression of TGF-β and MMP of human Tenons fibroblast
Zhang J-Y; Leng F; Peng S-M
International Journal of Ophthalmology 2007; 7: 1294-1297
19691 Ocular side effects of glaucoma treatment agents
Ehongo A; Bremer F
Bulletin de la Société Belge d'Ophtalmologie 2007; 304: 103-110
19910 Co-prescribing of topical and systemic β-blockers in patients with glaucoma: a quality use of medicine issue in Australian practice
Goldberg I; Adena MA
Clinical and Experimental Ophthalmology 2007; 35: 700-705
19789 Disease management programs for glaucoma: Has the vision become a reality?
Goldberg LD
Disease Management and Health Outcomes 2007; 15: 199-205
20035 Is there more to glaucoma treatment than lowering IOP?
Mozaffarieh M; Flammer J
Survey of Ophthalmology 2007; 52: S174-179
19672 Criteria for choosing clinically effective glaucoma treatment: A discussion panel consensus
Thygesen J; Burk R; Carassa R; Crichton A; Goni FJ; Menage M; Miglior S; Montgomery D; Nordmann J-P; Roberts T
Current Therapeutic Research - Clinical and Experimental 2007; 68: 127-136
19956 Pay more attention to early diagnosis and intervention for patients with primary glaucoma
Zhao JL
Zhonghua Yan Ke Za Zhi 2007; 43: 769-771
20079 Persistency rates for prostaglandin and other hypotensive eyedrops: population-based study using pharmacy claims data
Rait JL; Adena MA
Clinical and Experimental Ophthalmology 2007; 35: 602-611